[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336511-105":59,"doc-detail-336511-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","diagnostic-accuracy-of-esr1-mutation-detection-by-cell-free-dna-in-breast-cancer-a-systematic-review-and-meta-analysis-of-diagnostic-test-accuracy","Diagnostic accuracy of ESR1 mutation detection by cell-free DNA in breast cancer - a systematic review and meta-analysis of diagnostic test accuracy","","The estrogen receptor alpha gene (ESR1) is crucial in breast cancer biology, with nearly 70% of cases showing ER-positive status. Because metastatic disease can develop resistance linked to ESR1 ligand-binding domain mutations, early identification and monitoring are important. A systematic review and comprehensive meta-analysis evaluated diagnostic accuracy of cell-free DNA (cfDNA) testing for ESR1 mutations in breast cancer patients, using tissue biopsy as confirmation. Data from selected studies were synthesized to estimate sensitivity, specificity, accuracy, PPV, NPV, and likelihood ratios, demonstrating high diagnostic performance for plasma cfDNA.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/diagnostic-accuracy-of-esr1-mutation-detection-by-cell-free-dna-in-breast-cancer-a-systematic-review-and-meta-analysis-of-diagnostic-test-accuracy/336511/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/diagnostic-accuracy-of-esr1-mutation-detection-by-cell-free-dna-in-breast-cancer-a-systematic-review-and-meta-analysis-of-diagnostic-test-accuracy/336511.png","ImageObject",300,407,{"name":92,"@type":93},"Liam","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study’s main goal?","Question",{"text":112,"@type":113},"To assess diagnostic accuracy of ESR1 mutation detection using cell-free DNA (cfDNA) in breast cancer patients through a systematic review and comprehensive meta-analysis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which databases and cutoff date were used to search the literature?",{"text":117,"@type":113},"PubMed, Embase, and Web of Science were searched up to 6 April 2022.",{"name":119,"@type":110,"acceptedAnswer":120},"How were cfDNA diagnostic results verified?",{"text":121,"@type":113},"Included diagnostic studies measured ESR1 using cfDNA, with confirmation provided by tumor tissue biopsy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336511,1790127881,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Raei etal. BMC Cancer (2024) 24:908 BMC Cancer  \n[https://doi.org/10.1186/s12885-024-12674-z](https://doi.org/10.1186/s12885-024-12674-z)  \nSYSTEMATIC REVIEW Open Access  \nDiagnostic accuracy of ESR1 mutation detection by cell-free DNA in breast cancer:  \na systematic review and meta-analysis of diagnostic test accuracy  \nMaedeh Raei 1, Keyvan Heydari 1,2, Mohammad Tabarestani2, Alireza Razavi2, Fatemeh Mirshafiei2, Fatemeh Esmaeily2, MahsaTaheri3, Aref Hoseini2, Hojjatollah Nazari4, Danial Shamshirian5 and Reza Alizadeh-Navaei 1*  \nAbstract  \nBackground Estrogen receptors express in nearly 70% of breast cancers (ER-positive) . Estrogen receptor alpha plays a fundamental role as a significant factor in breast cancer progression for the early selection of therapeutic approaches. Accordingly, there has been a surge of attention to non-invasive techniques, including circulating Cell-free DNA (ccfDNA) or Cell-Free DNA (cfDNA), to detect and track ESR1 genotype. Therefore, this study aimed to examine the diagnosis accuracy of ESR1 mutation detection by cell-free DNA in breast cancer patientsthrough a systematic review and comprehensive meta-analysis.  \nMethods PubMed, Embase, and Web of Science databases were searched up to 6 April 2022. Diagnostic studies on ESR1 measurement by cfDNA, which was confirmed using the tumour tissue biopsy, have been included in the study. The sensitivity, specificity, accuracy, positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratio (PLR) and negative likelihood ratio (NLR) were considered to analyse the data.  \nResults Out of 649 papers, 13 papers with 15 cohorts, including 389 participants, entered the meta-analyses. The comprehensive meta-analysis indicated a high sensitivity (75 . 52, 95% CI 60 .19–90. 85), specificity (88 . 20, 95% CI 80.99– 95.40), and high accuracy of 88.96 (95% CI 83.23–94. 69) for plasma ESR1 . We also found a moderate PPV of 56.94 (95% CI 41 .70–72. 18) but a high NPV of 88.53 (95% CI 82.61–94.44) . We also found an NLR of 0.443 (95% CI 0.09–0. 79) and PLR of 1.60 (95% CI 1.20–1. 99) .  \nConclusion This systematic review and comprehensive meta-analysis reveal that plasma cfDNA testing exhibits high sensitivity and specificity in detecting ESR1 mutations in breast cancer patients. This suggests that the test could be a valuable diagnostic tool. It may serve as a dependable and non-invasive technique for identifying ESR1 mutations in breast cancer patients. However, more extensive research is needed to confirm its prognostic value.  \nKeywords ESR1, Breast cancer, Cell-free DNA, Diagnosis, Meta-analysis  \n*Correspondence:  \nReza Alizadeh-Navaei [reza_nava@yahoo.com](reza_nava@yahoo.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it.The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.To view a copy of this licence, visit [http://](http://)[ ](http://)[creativecommons.org/l](creativecommons.org/l)icenses/by-nc-nd/4.0/.  \nRaei et al. BMC Cancer (2024) 24:908  \nIntroduction  \nBreast cancer (BC) is the most prevalent neoplasm in women","cbCaiegyaSQNivLY","https://ap.wps.com/l/cbCaiegyaSQNivLY","pdf",2070558,13,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Breast cancer subtypes and estrogen receptor role\n## Clinical importance of ESR1 mutations in therapy resistance\n## Limitations of tissue biopsy and need for non-invasive monitoring","[{\"question\":\"What was the study’s main goal?\",\"answer\":\"To assess diagnostic accuracy of ESR1 mutation detection using cell-free DNA (cfDNA) in breast cancer patients through a systematic review and comprehensive meta-analysis.\"},{\"question\":\"Which databases and cutoff date were used to search the literature?\",\"answer\":\"PubMed, Embase, and Web of Science were searched up to 6 April 2022.\"},{\"question\":\"How were cfDNA diagnostic results verified?\",\"answer\":\"Included diagnostic studies measured ESR1 using cfDNA, with confirmation provided by tumor tissue biopsy.\"}]","Diagnostic accuracy of ESR1 mutation detection by cell-free DNA in breast cancer - a systematic review and meta-analysis of diagnostic test accuracy | PDF",1790015389,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/87eff12c7c6ebcf9dcb0791957092a27.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7622fa57b4518667a480b0210df7dffd.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4de80ae1354a86591eb32aa944a48db6.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/185920b1264448a3a4ee974ddc40834b.webp",980,1306]